Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass

This study has been terminated.
Information provided by:
Merck Sharp & Dohme Corp. Identifier:
First received: April 18, 2006
Last updated: May 24, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)